Abstract
Dietary retinyl palmitate was administered for 22-30 weeks in CD-1 mice which had been initiated with 0.15 μmol of 7,12-dimethylbenz[a]-anthracene (DMBA) and promoted with 8 nmol of 12-O-tetradecanoylphorbol-13-acetate (TPA) twice weekly thereafter. This treatment resulted in a dose response in both the tumoricidal capacity of a selected number of isolated peritoneal macrophages (PM) and in skin tumor prevention. At 350 I.U./g of diet, retinyl palmitate (RP) also resulted in a 3-fold increase in the number of DM. RP significantly increased the total capacity of macrophage host defenses by increasing the number and individual capacity for cytotoxicity. Selenium (Se), at 2 parts/million in the drinking water, did not enhance PM tumoricidal capacity, although it did result in 60% reduction of mouse tumor burden.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 181-187 |
| Number of pages | 7 |
| Journal | Cancer Letters |
| Volume | 36 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 1987 |
ASJC Scopus subject areas
- Oncology
- Cancer Research